Navigation Links
Koch Institute for Integrative Cancer Research Dedicated Today
Date:3/4/2011

CAMBRIDGE, Mass., March 4, 2011 /PRNewswire/ -- The new seven-story headquarters of the David H. Koch Institute for Integrative Cancer Research at MIT, where scientists and engineers are working together to pursue new ways to treat, detect and prevent cancer, will be officially dedicated today at 4 p.m.

The 365,000-square-foot building, designed by Cambridge-based architectural firm Ellenzweig, stretches along Main Street between Ames and Vassar streets, and houses 27 faculty labs and about 630 researchers, who began moving into the building in October 2010. Scientists and engineers work side-by-side in the new building, fostering collaborations between disciplines such as biology, chemical engineering, computer science, materials science and more.

"Under the leadership of Tyler Jacks, director of the Koch Institute, Koch researchers are cultivating frontier-breaking ideas at the remarkably fertile intersection of biology, engineering and the physical sciences," said MIT President Susan Hockfield.

Construction of the new building was made possible by a $100 million donation from David H. Koch '62, SM '63. That gift was announced in 2007 http://web.mit.edu/newsoffice/2007/koch-institute-1009.html.

"David Koch has supported MIT generously over many decades," said Hockfield, "and in this project he has been a true partner. I am grateful not only for his generosity, but also for the passion and insight he has brought to this ambitious undertaking."

"Of all of the things that I've done philanthropically,'' David Koch said, "playing a major role in the creation of this brilliant cancer institute at MIT is the one I'm most proud of. I hope that in time, hundreds of thousands, if not millions of lives, will be saved around the world because of therapies that originate here.''

The new Koch Institute joins a part of the MIT campus that has become a meeting ground for multidisciplinary collaboration in biotechnology and the life sciences. It is situated next to the Stata Center for Computer, Information and Intelligence Sciences; across the street from both the Broad Institute and the Whitehead Institute for Biomedical Research; and within walking distance of the MIT Brain and Cognitive Sciences complex. Dozens of biotech and biopharmaceutical companies are located nearby.

The new building (also known as MIT Building 76) replaces the Koch Institute's former headquarters in Buildings 17 and 18. Most of the engineers who have joined the cancer biologists in the new facility formerly had labs scattered across campus.

All of the building's common areas are clustered in the center of the building, to help promote chance encounters that could lead to new research collaborations.

The new building also features the Swanson Biotechnology Center, a 20,000-square-foot cluster of "core facilities" that offer researchers access to cutting-edge technology that their individual labs likely could not afford to purchase. Those include technology for cell imaging, DNA sequencing and nanomaterial characterization.

In addition to lab and meeting space, the building also features a ground-floor exhibition gallery that will be home to a changing display of art and information on MIT's leadership role in the life sciences.

Koch Institute research is currently focused around five key target areas:  nanotechnology therapy, detection and monitoring, metastasis, personalized medicine, and the immune system. Research and development in each of these areas involves cross-disciplinary teams of faculty, students, and staff – and will also encompass collaborations with clinical centers and industry.

"I am optimistic that the work of the Koch Institute will have an important effect on patients' lives, in the near term," said Tyler Jacks, Director of the Koch Institute and the David H. Koch Professor of Biology at MIT.

"I expect the research that we do will lead to more effective treatments, better ways to monitor the disease, and -- one day -- to prevent it altogether."

http://web.mit.edu/ki

http://web.mit.edu/newsoffice/2010/koch-courtyard-slideshow.html

http://web.mit.edu/newsoffice/2010/koch-opening.html

http://web.mit.edu/newsoffice/2008/cancer-groundbreak-0308.html


'/>"/>
SOURCE MIT News Office
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
2. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
3. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
4. Cyntellect to Collaborate With the Burnham Institute for Medical Research
5. Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute
6. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
7. Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
8. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
9. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
10. Annual List of Best Doctors in Dallas Showcases Texas Institute for Surgery Physicians
11. LifeModeler, Inc. Provides $400,000 Grant to InMotion Musculoskeletal Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... ... The leading Regenerative Veterinary Medicine Company, VetStem Biopharma ., is proud ... of their own patients with the VetStem Cell Therapy. Each of these veterinarians has ... patients. , The veterinarians are Dr Ross Rich former owner of Cave Creek ...
(Date:5/19/2016)... ... ... Anton Paar USA, located in Ashland, Virginia is pleased to announce that construction ... a third office building to the current facilities. , Growth is nothing new. ... with office space adjacent to the previous main building. Through remodels and new construction, ...
(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... , May 18, 2016 The Biotech ... does not mean that there are no opportunities ahead. Today, ... Inc. (NASDAQ: THLD ), Seattle Genetics Inc. (NASDAQ: ... ), and Ophthotech Corp. (NASDAQ: OPHT ). Sign ... at: http://www.activewallst.com/ Threshold Pharmaceuticals ...
Breaking Biology Technology:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):